Paul Edward Kelly
Director, RELMADA THERAPEUTICS, INC.
Companies
- RELMADA THERAPEUTICS, INC.Board member Nov 16, 2015 to now1
- RELMADA THERAPEUTICS, INC.Chief operating officer May 20, 2025 to Nov 6, 20252
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- RELMADA THERAPEUTICS, INC. RLMD502,295 shares3$1.6M at $3.17Nov 5, 2025
As of each latest filing. The line shows shares held over time.
Recent filings
- Nov 5, 2025Bought 90,000 shares at $2.20 of RELMADA THERAPEUTICS, INC.3
- May 16, 2025Bought 200,000 shares at $0.43 of RELMADA THERAPEUTICS, INC.4
- Sep 9, 2024Bought 25,000 shares at $2.59 of RELMADA THERAPEUTICS, INC.5
- Apr 4, 2022Sold 10,000 shares at $30.04 of RELMADA THERAPEUTICS, INC.6
- Apr 4, 2022Exercised options 10,000 shares at $3.24 of RELMADA THERAPEUTICS, INC.6
- Jan 3, 2022Exercised options 20,000 shares at $3.24 of RELMADA THERAPEUTICS, INC.7
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4SEC EDGARForm 4 filed May 20, 2025
- 5SEC EDGARForm 4 filed Sep 11, 2024
- 6SEC EDGARForm 4 filed Apr 5, 2022
- 7SEC EDGARForm 4 filed Jan 5, 2022